Cargando…
Angiogenic mRNA and microRNA Gene Expression Signature Predicts a Novel Subtype of Serous Ovarian Cancer
Ovarian cancer is the fifth leading cause of cancer death for women in the U.S. and the seventh most fatal worldwide. Although ovarian cancer is notable for its initial sensitivity to platinum-based therapies, the vast majority of patients eventually develop recurrent cancer and succumb to increasin...
Autores principales: | Bentink, Stefan, Haibe-Kains, Benjamin, Risch, Thomas, Fan, Jian-Bing, Hirsch, Michelle S., Holton, Kristina, Rubio, Renee, April, Craig, Chen, Jing, Wickham-Garcia, Eliza, Liu, Joyce, Culhane, Aedin, Drapkin, Ronny, Quackenbush, John, Matulonis, Ursula A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278409/ https://www.ncbi.nlm.nih.gov/pubmed/22348002 http://dx.doi.org/10.1371/journal.pone.0030269 |
Ejemplares similares
-
Stem Cell-Like Gene Expression in Ovarian Cancer Predicts Type II Subtype and Prognosis
por: Schwede, Matthew, et al.
Publicado: (2013) -
High Throughput Interrogation of Somatic Mutations in High Grade Serous Cancer of the Ovary
por: Matulonis, Ursula A., et al.
Publicado: (2011) -
iBBiG: iterative binary bi-clustering of gene sets
por: Gusenleitner, Daniel, et al.
Publicado: (2012) -
Whole-Genome Gene Expression Profiling of Formalin-Fixed, Paraffin-Embedded Tissue Samples
por: April, Craig, et al.
Publicado: (2009) -
Significance Analysis of Prognostic Signatures
por: Beck, Andrew H., et al.
Publicado: (2013)